Sara Elena Rebuzzi

30PUBLICATIONS
125CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation and matterRadiation therapyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 22, 2026
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.

|Feb 13, 2025
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience.

Maria Silvia De Feo, Luca Filippi, Matteo Bauckneht

|Aug 19, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab.

Alessandra Damassi, Malvina Cremante, Alessio Signori

|Jun 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).

Fabio Catalano, Matteo Brunelli, Alessio Signori

|May 17, 2024
Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau".

Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori

|Apr 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).

Fabio Catalano, Matteo Brunelli, Alessio Signori

Pageof 5

Frequent Collaborators

19 joint publications

Giuseppe Fornarini

14 joint publications

Sebastiano Buti

13 joint publications

Giuseppe Luigi Banna

9 joint publications

Alessio Signori